Table 2.

Clinicopathological features of Indonesian breast cancer patients with deleterious BRCA1 or BRCA2 germline mutations

Patient	Agea	Gene with germline mutation	Mutationb	stage	Diagnosis	Menopausal status	family history of cancer	Survival status
AE	25	BRCA1	c.2784_2785insT	IIIB/IIIA	IDC, bilateral	pre	No	DOD 9 w
B10	31	BRCA1	p.Leu1415X	I	IDC	pre	No	DOD 57 w
AA	40	BRCA1	-c	IIIB	IDC N+	pre	No	AWD
AB	34	BRCA2	c.3040_3043del4	IIIB	IDC N+	pre	Sister, Int	DOD 17 w
B5	63	BRCA2	p.Glu2183X	IV	Tubular	post	Sister,Br	AWD
B6	65	BRCA2	p.Glu2183X	III	IDC	post	Brother, Br	AWD
B-III-5	30	BRCA2	p.Leu824X	I	IDC	pre	No	AWD
AZ	40	BRCA2	p.Leu824X	IV	IDC	pre	Sister, Cv	DOD 46 w
W-II	37	BRCA2	p.Gln2894X	IIIA	IDC	pre	No	DOD 107 w

^aAge at time of diagnosis

^bGen Bank Accession number, BRCA1: U14680, BRCA2: U43746

^cnot determined, detected by MLPA

IDC: invasive ductal carcinoma; DOD: dead of disease; bil: bilateral breast cancer; N+: with metastatic to lymph node; Int: intestinum cancer, Br: breast cancer; Cv: cervical cancer